Home › Research › Biomarkers
Polygenic scores of Core 1 Alzheimer's disease biomarkers predict early cognitive and pathological change
Yuexuan Xu, Min Qiao, Tamil I Gunasekaran, Yian Gu, Dolly Reyes-Dumeyer, Angel Piriz, Danurys Sanchez, Belisa Soriano et al.. Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025-11
Topic: Genetics and APOE
Plain-language summary
The Core 1 biomarker PGSs predicted AD pathology and associated cognitive performance better than the AD PGSs in both populations. The Core 1 PGSs show improved predictive value for AD-related plasma biomarkers and early cognitive changes. HIGHLIGHTS: APOE ε4 explained more variance in plasma p-tau217 than in plasma p-tau181. PGSs based on Core 1 biomarkers outperformed AD PGSs in predicting plasma biomarkers and cognitive decline among asymptomatic individuals in non-Hispanic White and Hispanic individuals. However, the improvement in predictive power was modest and may vary by age. While the variance in p-tau181 and p-tau217 explained by individual Core 1 PGSs remains limited, the distinct genetic signals captured by the best-performing PGSs across different Core 1 biomarkers may provide an opportunity for developing an integrative Core 1 PGS that more effectively predicts plasma p-tau181 and p-tau217 levels than AD-based PGS.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Xu, Y., Qiao, M., Gunasekaran, T. I., Gu, Y., Reyes-Dumeyer, D., Piriz, A., et al. (2025). Polygenic scores of Core 1 Alzheimer's disease biomarkers predict early cognitive and pathological change. Alzheimer's & dementia : the journal of the Alzheimer's Association. https://doi.org/10.1002/alz.70937
Vancouver
Xu Y, Qiao M, Gunasekaran TI, Gu Y, Reyes-Dumeyer D, Piriz A, et al. Polygenic scores of Core 1 Alzheimer's disease biomarkers predict early cognitive and pathological change. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2025. doi:10.1002/alz.70937. PMID: 41307156.
BibTeX
@article{xu2025-41307156,
author = {Xu, Yuexuan and Qiao, Min and Gunasekaran, Tamil I and Gu, Yian and Reyes-Dumeyer, Dolly and Piriz, Angel and Sanchez, Danurys and Soriano, Belisa and others},
title = {{Polygenic scores of Core 1 Alzheimer's disease biomarkers predict early cognitive and pathological change}},
journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
year = {2025},
doi = {10.1002/alz.70937},
pmid = {41307156},
url = {https://doi.org/10.1002/alz.70937}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- The Core 1 biomarker PGSs predicted AD pathology and associated cognitive performance better than the AD PGSs in both populations.
- The Core 1 PGSs show improved predictive value for AD-related plasma biomarkers and early cognitive changes.
- HIGHLIGHTS: APOE ε4 explained more variance in plasma p-tau217 than in plasma p-tau181.
- PGSs based on Core 1 biomarkers outperformed AD PGSs in predicting plasma biomarkers and cognitive decline among asymptomatic individuals in non-Hispanic White and Hispanic individuals.
- However, the improvement in predictive power was modest and may vary by age.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Study designlongitudinal study
- Participants515
- Evidence strengthModerate
How this study scored 71/100
Published in a leading specialty journal, and it is a longitudinal study following the same people over time. Scored zero for effect reported and randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record, multicenter collaboration and free to read, so those were left out: it earned 40 of the 56 points we could judge it on, which is 71 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Alzheimer's & dementia : the journal of the Alzheimer's Association) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 7 / 12 | A longitudinal study following the same people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 2 / 4 | 515 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41307156) |
| Free to read | — / 2 | Access not recorded — left out of this score |
| Points | 40 / 56 | Scored on 10 of 20 parts. We have no data for the rest, so they are left out: 40 of the 56 points we could judge it on is 71 out of 100. |
| Total | 71 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Biomarkers from nearby years
Also tagged “p-tau217”
692 studies in the library carry the topic tag “p-tau217”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 692 tagged studies.